THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;MRIGLOBAL - ESTADOS UNIDOS DE AMERICA GLG PHARMA, LLC
发明人:
SHOEMAKER ROBERT H.,WHITE JONATHAN M.,GUPTA SHANKER,LOVELL MICHAEL W.
申请号：
CL2019002843
公开号：
CL2019002843A1
申请日:
2019.10.04
申请国别(地区):
CL
年份:
2020
代理人:
摘要：
A prepared STAT3 inhibitor salt, namely benzoic acid 2-hydroxy-4 -, [2 - [(4-methylphenyl (I) sulfuric acid) acetamide] and 2-amino-2 - (hydroxy) - 1-propenedi. Salt can be dissolved in water and remain stable for a long time. In addition, pharmaceutical compounds including salt and salt management methods are provided to prevent and treat diseases such as breast cancer.<；p>；SE DIVULGA UNA SAL PREPARADA DEL INHIBIDOR DE STAT3 CONOCIDO COMO Á；CIDO BENZOICO 2-HIDROXI-4-,[2-[[(4-METILFEN I)SULFONILLOXI]ACETILLAMINO] Y 2-AMINO-2-(HIDROXIMETIL)-1 3- PROPANEDIOL. LA SAL ES SOLUBLE EN AGUA Y ESTABLE POR PERIODOS DE TIEMPO PROLONGADOS. ADEMÁ；S SE PROPORCIONAN COMPOSICIONES FARMACÉ；UTICAS QUE COMPRENDEN LA SAL Y LOS MÉ；TODOS DE ADMINISTRACIÓ；N DE LA SAL PARA PREVENIR Y TRATAR EL CÁ；NCER, COMO EL CÁ；NCER DE MAMA.<；/p>；
